How has the US market performed recently?

The US market dropped 4.1% over the past week but remains up 21% over the last year.

What is the earnings growth forecast for the US market?

Earnings are forecast to grow by 18% annually.

Does the report recommend buying AbbVie stock?

No, the report does not provide a buy or sell recommendation; it only suggests the stock may be undervalued.

AbbVie Among 3 Stocks That May Be Undervalued by Current Market Estimates

With the US market dropping 4.1% over the past week, analysts suggest stocks like AbbVie (ABBV) may be undervalued based on current market estimates, presenting potential opportunities for value investors.

June 11, 2026

2 min read

Source: Simply Wall St.

Key Numbers

market drop 7d

4.1%

market gain 1y

21%

earnings growth forecast

18% annually

According to an analysis by Simply Wall St., the US market has experienced a 4.1% decline over the past seven days, though it remains up 21% over the last year with earnings forecast to grow 18% annually. In these fluctuating conditions, analysts identify certain stocks that may be undervalued based on current market estimates.

Recommendation Change

The report does not specify a rating change for AbbVie (ABBV) but includes it among stocks believed to be undervalued relative to current market estimates.

Analyst Rationale

The analysis focuses on the idea that the current valuation does not fully reflect the company's future growth potential, especially given the strong earnings growth forecast for the overall market.

Context

This assessment comes amid volatility in the healthcare sector, but AbbVie maintains its position as a leading biopharmaceutical company. Other analysts have mixed views, but the consensus suggests the stock may offer value for investors.

What We Conclude

While the analysis does not provide a buy or sell recommendation, it highlights that AbbVie may be undervalued under current market conditions, warranting attention from investors ahead of upcoming financial reports.

Frequently Asked Questions

The report did not explicitly name all three stocks, but it indicated that AbbVie (ABBV) is among them.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.